Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1353

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 5
Chunk 1353
---

    $0  
    $0  
    $44,000 

    Alison W. Brady 
    2024  
    $40,000  
    $0  
    $0  
    $40,000 

Director
Agreements

On
September 8, 2021, the Company entered into Independent Director Agreements with each of Allison Brady, Holger Weis, Julie Kampf and
Nick Hemmerly (each, a “Director”) relating to their service as independent directors of the Company.

114

Pursuant
to each of the agreements, the Director agreed to serve as an independent director of the Company and to perform the duties consistent
with such position. In addition, pursuant to their respective agreements, Ms. Brady agreed to serve as a member of the Compensation Committee
and Audit Committee; Mr. Weis agreed to serve as a member of the Nomination Committee and the Chairman of the Audit Committee; Ms. Kampf
agreed to serve as a member of the Compensation Committee and as Chairman of the Nomination Committee of the Board; and Mr. Hemmerly
agreed to serve as Chairman of the Compensation Committee as well as a member of the Audit Committee and Nominating Committee.

Each
of the Directors confirmed that the Director is independent (as such term has been construed under Delaware law with respect to directors
of Delaware corporations and the OTC Markets, the NASDAQ Stock Exchange and the New York Stock Exchange). Each Director also confirmed
that, to their knowledge, (a) that Director does not possess material business, close personal relationships or other affiliations, or
any history of any such material business, close personal relationships or other affiliations, with the Company’s significant equity
or debt holders or any of their respective corporate affiliates that would cause that Director to be unable to (i) exercise independent
judgment based on the best interests of the Company or (ii) make decisions and carry out that Director’s responsibilities as a
director of the Company, in each case in accordance with the terms of the Company’s governing documents and applicable law, and
(b) that they have no existing relationship or affiliation of any kind with any entity that the applicable Director knows to be a competitor
of the Company.

Each
of the agreements continues until the earliest of (a) such time as the Director resigns or is removed in accordance with the Company’s
governing documents, and (b) the death of the Director